Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)

Identification of post-kala-azar dermal leishmaniasis (PKDL) is important due to the long and toxic treatment and the fact that PKDL patients may serve as a reservoir for visceral leishmaniasis (VL). We summarized the published literature about the accuracy of diagnostic tests for PKDL. We searched...

Full description

Bibliographic Details
Main Authors: Emily R. Adams, Inge Versteeg, Mariska M. G. Leeflang
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2013/150746
id doaj-a43005082a3844c6a89a2abef3692052
record_format Article
spelling doaj-a43005082a3844c6a89a2abef36920522020-11-24T22:35:00ZengHindawi LimitedJournal of Tropical Medicine1687-96861687-96942013-01-01201310.1155/2013/150746150746Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)Emily R. Adams0Inge Versteeg1Mariska M. G. Leeflang2Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKRoyal Tropical Institute, KIT Biomedical Research, 1105 AZ Amsterdam, The NetherlandsDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The NetherlandsIdentification of post-kala-azar dermal leishmaniasis (PKDL) is important due to the long and toxic treatment and the fact that PKDL patients may serve as a reservoir for visceral leishmaniasis (VL). We summarized the published literature about the accuracy of diagnostic tests for PKDL. We searched Medline for eligible studies investigating the diagnostic accuracy of any test for PKDL. Study quality was assessed using QUADAS-2. Data were extracted from 21 articles including 43 separate studies. Twenty-seven studies evaluated serological tests (rK39 dipstick, ELISA, DAT, and leishmanin tests), six studies molecular tests, eight microscopy, and two cultures. Only a few of these studies reported a valid estimate of diagnostic accuracy, as most were case-control designs or used a reference standard with low sensitivity. The included studies were very heterogeneous, for example, due to a large variety of reference standards used. Hence, no summary estimates of sensitivity or specificity could be made. We recommend well-designed diagnostic accuracy trials that evaluate, side-by-side, all currently available diagnostics, including clinical symptoms, serological, antigen, molecular, and parasitological tests and possible use of statistical modelling to evaluate diagnostics when there is no suitable gold standard.http://dx.doi.org/10.1155/2013/150746
collection DOAJ
language English
format Article
sources DOAJ
author Emily R. Adams
Inge Versteeg
Mariska M. G. Leeflang
spellingShingle Emily R. Adams
Inge Versteeg
Mariska M. G. Leeflang
Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
Journal of Tropical Medicine
author_facet Emily R. Adams
Inge Versteeg
Mariska M. G. Leeflang
author_sort Emily R. Adams
title Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
title_short Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
title_full Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
title_fullStr Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
title_full_unstemmed Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
title_sort systematic review into diagnostics for post-kala-azar dermal leishmaniasis (pkdl)
publisher Hindawi Limited
series Journal of Tropical Medicine
issn 1687-9686
1687-9694
publishDate 2013-01-01
description Identification of post-kala-azar dermal leishmaniasis (PKDL) is important due to the long and toxic treatment and the fact that PKDL patients may serve as a reservoir for visceral leishmaniasis (VL). We summarized the published literature about the accuracy of diagnostic tests for PKDL. We searched Medline for eligible studies investigating the diagnostic accuracy of any test for PKDL. Study quality was assessed using QUADAS-2. Data were extracted from 21 articles including 43 separate studies. Twenty-seven studies evaluated serological tests (rK39 dipstick, ELISA, DAT, and leishmanin tests), six studies molecular tests, eight microscopy, and two cultures. Only a few of these studies reported a valid estimate of diagnostic accuracy, as most were case-control designs or used a reference standard with low sensitivity. The included studies were very heterogeneous, for example, due to a large variety of reference standards used. Hence, no summary estimates of sensitivity or specificity could be made. We recommend well-designed diagnostic accuracy trials that evaluate, side-by-side, all currently available diagnostics, including clinical symptoms, serological, antigen, molecular, and parasitological tests and possible use of statistical modelling to evaluate diagnostics when there is no suitable gold standard.
url http://dx.doi.org/10.1155/2013/150746
work_keys_str_mv AT emilyradams systematicreviewintodiagnosticsforpostkalaazardermalleishmaniasispkdl
AT ingeversteeg systematicreviewintodiagnosticsforpostkalaazardermalleishmaniasispkdl
AT mariskamgleeflang systematicreviewintodiagnosticsforpostkalaazardermalleishmaniasispkdl
_version_ 1725725183153537024